889 related articles for article (PubMed ID: 25698172)
1. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.
Modvig S; Degn M; Roed H; Sørensen TL; Larsson HB; Langkilde AR; Frederiksen JL; Sellebjerg F
Mult Scler; 2015 Dec; 21(14):1761-70. PubMed ID: 25698172
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
Møllgaard M; Degn M; Sellebjerg F; Frederiksen JL; Modvig S
Eur J Neurol; 2016 May; 23(5):898-905. PubMed ID: 26872061
[TBL] [Abstract][Full Text] [Related]
3. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
Brain; 2015 Apr; 138(Pt 4):918-31. PubMed ID: 25688078
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.
Modvig S; Degn M; Sander B; Horwitz H; Wanscher B; Sellebjerg F; Frederiksen JL
Mult Scler; 2016 Apr; 22(5):590-8. PubMed ID: 26283696
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.
Comabella M; Fernández M; Martin R; Rivera-Vallvé S; Borrás E; Chiva C; Julià E; Rovira A; Cantó E; Alvarez-Cermeño JC; Villar LM; Tintoré M; Montalban X
Brain; 2010 Apr; 133(Pt 4):1082-93. PubMed ID: 20237129
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
Matute-Blanch C; Villar LM; Álvarez-Cermeño JC; Rejdak K; Evdoshenko E; Makshakov G; Nazarov V; Lapin S; Midaglia L; Vidal-Jordana A; Drulovic J; García-Merino A; Sánchez-López AJ; Havrdova E; Saiz A; Llufriu S; Alvarez-Lafuente R; Schroeder I; Zettl UK; Galimberti D; Ramió-Torrentà L; Robles R; Quintana E; Hegen H; Deisenhammer F; Río J; Tintoré M; Sánchez A; Montalban X; Comabella M
Brain; 2018 Apr; 141(4):1085-1093. PubMed ID: 29452342
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of prognostic biomarkers in optic neuritis.
Tejeda-Velarde A; Costa-Frossard L; Sainz de la Maza S; Carrasco Á; Espiño M; Picón C; Toboso I; Walo PE; Lourido D; Muriel A; Álvarez-Cermeño JC; Villar LM
Eur J Neurol; 2018 Apr; 25(4):614-618. PubMed ID: 29272057
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis.
Modvig S; Degn M; Horwitz H; Cramer SP; Larsson HB; Wanscher B; Sellebjerg F; Frederiksen JL
PLoS One; 2013; 8(10):e77163. PubMed ID: 24116216
[TBL] [Abstract][Full Text] [Related]
9. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis.
Hinsinger G; Galéotti N; Nabholz N; Urbach S; Rigau V; Demattei C; Lehmann S; Camu W; Labauge P; Castelnovo G; Brassat D; Loussouarn D; Salou M; Laplaud D; Casez O; Bockaert J; Marin P; Thouvenot E
Mult Scler; 2015 Sep; 21(10):1251-61. PubMed ID: 25698171
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
Eur J Neurol; 2017 May; 24(5):703-712. PubMed ID: 28261960
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.
Quintana E; Coll C; Salavedra-Pont J; Muñoz-San Martín M; Robles-Cedeño R; Tomàs-Roig J; Buxó M; Matute-Blanch C; Villar LM; Montalban X; Comabella M; Perkal H; Gich J; Ramió-Torrentà L
Eur J Neurol; 2018 Sep; 25(9):1189-1191. PubMed ID: 29797629
[TBL] [Abstract][Full Text] [Related]
12. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
[TBL] [Abstract][Full Text] [Related]
13. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
Martínez MA; Olsson B; Bau L; Matas E; Cobo Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
[TBL] [Abstract][Full Text] [Related]
15. Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.
Boesen MS; Jensen PEH; Magyari M; Born AP; Uldall PV; Blinkenberg M; Sellebjerg F
Mult Scler Relat Disord; 2018 Aug; 24():175-183. PubMed ID: 30055504
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.
Sellebjerg F; Royen L; Soelberg Sørensen P; Oturai AB; Jensen PEH
Mult Scler; 2019 Oct; 25(11):1444-1451. PubMed ID: 30113249
[TBL] [Abstract][Full Text] [Related]
17. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome.
van der Vuurst de Vries RM; Wong YYM; Mescheriakova JY; van Pelt ED; Runia TF; Jafari N; Siepman TA; Melief MJ; Wierenga-Wolf AF; van Luijn MM; Samijn JP; Neuteboom RF; Hintzen RQ
Mult Scler; 2019 Jun; 25(7):958-967. PubMed ID: 29774770
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of CSF neurofilament light and heavy chain protein in MS.
Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
[TBL] [Abstract][Full Text] [Related]
19. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
20. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
Peng L; Bi C; Xia D; Mao L; Qian H
Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
